Who
Rhonda M. Chicko
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Cyclerion Therapeutics; Chief Financial Officer, Scholar Rock Holding.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 29 May 2018
- Last trade
- 14 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 18 Aug 2026 | Cyclerion TherapeuticsBiotechnology | SEC FORM 4 Code M | $59K25,000 at $2.36 | filing |
| 14 Aug 2026filed 18 Aug 2026 | Cyclerion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | Cyclerion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | Cyclerion TherapeuticsBiotechnology | SEC FORM 4 Code M | $59K25,000 at $2.36 | filing |
| 7 Aug 2025filed 11 Aug 2025 | Cyclerion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 31 Jan 2019filed 4 Feb 2019 | SRRK Scholar Rock Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —56,000 at $0.00 | filing |
| 29 May 2018filed 31 May 2018 | SRRK Scholar Rock Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,208 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.